Connect with us
Tilray Brands acquired HelloMD, a digital healthcare and medical cannabis platform, pending court approval on June 29, 2026. The deal adds telehealth, education, and patient engagement...
Tilray (TLRY) fell 3.32% to $4.44, remaining below key moving averages and signaling continued bearish pressure. Despite a £1 million BrewDog promotion boosting engagement and sales...
The international cannabis industry is shifting, with North America facing pricing and regulatory challenges while Europe, especially medical cannabis, becomes a key growth region. Tilray Brands...
Cannabis stocks, including Tilray, plunged after a 2021 speculative peak, remaining in long-term decline. Momentum may shift as U.S. authorities consider reclassifying cannabis. Tilray shows technical...
Tilray’s Q3 2025 results show $186 million in revenue, down year-over-year, with a reduced full-year forecast of $850–900 million. While margins in its cannabis division rose...
Aurora Cannabis is one of the main companies in the cannabis sector, listed on both the Toronto Stock Exchange and the Nasdaq, both of which have...
Tilray closed the third quarter of 2022 with revenues of $151.87 million. In the previous quarter, the company had recorded revenues of $123.9 million. The proceeds...